Cell Line : LCLC-103H
Cellosaurus Index : CVCL_1375
Cellosaurus ID : LCLC-103H
CCLE Name
: LCLC103H_LUNG
GDSC1 Name
, GDSC2 Name
: LCLC-103H
CTRP1 Name
, CTRP2 Name
: LCLC103H
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LCLC-103H | (-)-gallocatechin-3-monogallate | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | 2-bromopyruvate | CTRP1 | 0.2603 | 37.0000 |
|
| LCLC-103H | 2-deoxyglucose | CTRP1 | 0.2890 | 37.0080 |
|
| LCLC-103H | 2-fluoropalmitic acid | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 3-chloro-L-alanine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | 4-methylfasudil | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| LCLC-103H | 5-benzyl-9-tert-butyl-paullone | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LCLC-103H | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 6-diazo-5-oxo-L-norleucine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 6-NBDG | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 7-nitroindazole | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | ABH | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | ABT-751 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ABT737 | GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LCLC-103H | AGK-2 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LCLC-103H | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LCLC-103H | Alda-1 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | alpha-cyano-4-hydroxycinnamic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| LCLC-103H | AM-580 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LCLC-103H | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LCLC-103H | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| LCLC-103H | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | aspirin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AT7867 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| LCLC-103H | avrainvillamide | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LCLC-103H | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LCLC-103H | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LCLC-103H | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LCLC-103H | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | batimastat | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Bax channel blocker | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| LCLC-103H | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LCLC-103H | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LCLC-103H | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LCLC-103H | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| LCLC-103H | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | BEC | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | betulinic acid | CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | Bexarotene | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | BI-2536 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| LCLC-103H | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | bistramide A | CTRP1 | 0.2517 | 32.2330 |
|
| LCLC-103H | BIX-01294 | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| LCLC-103H | BIX-01338 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | blebbistatin | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| LCLC-103H | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| LCLC-103H | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BMS-191011 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BMS-536924 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0023 | 37.0000 |
|
| LCLC-103H | BMS-641988 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Bortezomib | GDSC2,CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LCLC-103H | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | bovinocidin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| LCLC-103H | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K03911514 | CTRP2 | 0.0020 | 17.0000 |
|
| LCLC-103H | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| LCLC-103H | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| LCLC-103H | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| LCLC-103H | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| LCLC-103H | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | BRD2649 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| LCLC-103H | BRD4770 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD63610 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BRD6368 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD7137 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | BRD9786 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LCLC-103H | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| LCLC-103H | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | C6-ceramide | CTRP2 | 0.0020 | 17.0000 |
|
| LCLC-103H | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LCLC-103H | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LCLC-103H | capsaicin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| LCLC-103H | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LCLC-103H | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LCLC-103H | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LCLC-103H | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LCLC-103H | CD-1530 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LCLC-103H | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| LCLC-103H | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | CHEMBL399379 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| LCLC-103H | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| LCLC-103H | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| LCLC-103H | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| LCLC-103H | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| LCLC-103H | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| LCLC-103H | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| LCLC-103H | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LCLC-103H | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Compound 10b | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Compound 110 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Compound 12 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Compound 2 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Compound 4 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Compound 44 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LCLC-103H | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Crizotinib | GDSC2,CTRP2,CCLE | 0.0010 | 66.0000 |
|
| LCLC-103H | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | cytosporone B | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LCLC-103H | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| LCLC-103H | Dactolisib | GDSC1,GDSC2 | 0.0003 | 2.0000 |
|
| LCLC-103H | dalcetrapib | CTRP1 | 0.2587 | 33.1000 |
|
| LCLC-103H | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.0000 |
|
| LCLC-103H | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LCLC-103H | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | DG-041 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | dichloroacetic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | DL-TBOA | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LCLC-103H | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| LCLC-103H | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | eflornithine | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| LCLC-103H | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| LCLC-103H | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| LCLC-103H | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| LCLC-103H | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LCLC-103H | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| LCLC-103H | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LCLC-103H | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | ethylidene glucose | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LCLC-103H | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| LCLC-103H | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | fatostatin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Fedratinib | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LCLC-103H | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LCLC-103H | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| LCLC-103H | fluoropyruvate | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | FMK-PA | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | fosfomycin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LCLC-103H | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LCLC-103H | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Fulvestrant | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LCLC-103H | fumagillol | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| LCLC-103H | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Gemcitabine | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0001 | 37.0000 |
|
| LCLC-103H | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | glibenclamide | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| LCLC-103H | Gly-Gly-PALO | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LCLC-103H | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LCLC-103H | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LCLC-103H | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LCLC-103H | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| LCLC-103H | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| LCLC-103H | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| LCLC-103H | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| LCLC-103H | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | GW-405833 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | idarubicin | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Imatinib | CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | importazole | CTRP2 | 0.0061 | 50.0000 |
|
| LCLC-103H | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| LCLC-103H | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LCLC-103H | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Irinotecan | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| LCLC-103H | iso-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LCLC-103H | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LCLC-103H | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| LCLC-103H | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | JZL-184 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | kinetin riboside | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| LCLC-103H | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LCLC-103H | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | L-685458 | CTRP2,CTRP1,CCLE | 0.0011 | 37.0000 |
|
| LCLC-103H | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LCLC-103H | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LCLC-103H | Lenalidomide | GDSC1,GDSC2,CTRP1 | 0.0100 | 37.0000 |
|
| LCLC-103H | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | leucascandrolide A | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| LCLC-103H | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Linifanib | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | lonidamine | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | losartan | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| LCLC-103H | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | LY-2365109 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | m-3M3-FBS | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| LCLC-103H | maraviroc | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LCLC-103H | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LCLC-103H | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| LCLC-103H | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LCLC-103H | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| LCLC-103H | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| LCLC-103H | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | MK-591 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | ML006 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | ML007 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | ML013 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML037 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ML038 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ML039 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ML050 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML101 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | ML203 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| LCLC-103H | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LCLC-103H | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LCLC-103H | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| LCLC-103H | N-oxalyl-D-phenylalanine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | N5-iminoethyl-L-ornithine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| LCLC-103H | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Navitoclax | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LCLC-103H | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | neopeltolide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | nifedipine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| LCLC-103H | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | NSC23766 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LCLC-103H | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | NSC632839 | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| LCLC-103H | NSC95397 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LCLC-103H | Nutlin-3a | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0025 | 150.0000 |
|
| LCLC-103H | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Olaparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LCLC-103H | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| LCLC-103H | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | OSI-930 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | OSW-1 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | Oxaliplatin | GDSC2,CTRP2 | 0.0100 | 66.0000 |
|
| LCLC-103H | oxythiamine | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | PAC-1 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0000 | 66.0000 |
|
| LCLC-103H | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| LCLC-103H | pandacostat | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LCLC-103H | panduratin A | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LCLC-103H | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| LCLC-103H | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LCLC-103H | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| LCLC-103H | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | Pemetrexed | GDSC1,CTRP1 | 0.0100 | 37.0000 |
|
| LCLC-103H | Pevonedistat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PF-3845 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LCLC-103H | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LCLC-103H | phloretin | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| LCLC-103H | PI-103 | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| LCLC-103H | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | PIK-75 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Piperlongumine | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LCLC-103H | pluripotin | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LCLC-103H | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| LCLC-103H | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LCLC-103H | PP-30 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| LCLC-103H | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | PT-630 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| LCLC-103H | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| LCLC-103H | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | QS11 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | quinoclamine | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | racemic-2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| LCLC-103H | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | RAF265 | CTRP2,CCLE | 0.0020 | 33.0000 |
|
| LCLC-103H | Rapamycin | GDSC2,CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| LCLC-103H | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Regorafenib | CTRP2 | 0.0320 | 66.0000 |
|
| LCLC-103H | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | RepSox | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LCLC-103H | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Ro-28-1675 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| LCLC-103H | rosiglitazone | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | rotenone | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LCLC-103H | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| LCLC-103H | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| LCLC-103H | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| LCLC-103H | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| LCLC-103H | Selumetinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 270.0000 |
|
| LCLC-103H | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LCLC-103H | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LCLC-103H | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LCLC-103H | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LCLC-103H | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| LCLC-103H | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LCLC-103H | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LCLC-103H | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| LCLC-103H | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LCLC-103H | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LCLC-103H | sildenafil | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| LCLC-103H | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LCLC-103H | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LCLC-103H | SKI-II | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| LCLC-103H | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | SN-38 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| LCLC-103H | SNS-032 | CTRP2 | 0.0020 | 17.0000 |
|
| LCLC-103H | SNX-2112 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LCLC-103H | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | sparfosic acid | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Staurosporine | GDSC2,CTRP2 | 0.0001 | 3.3000 |
|
| LCLC-103H | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | SU11274 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | T-5345967 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| LCLC-103H | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LCLC-103H | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| LCLC-103H | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Tanespimycin | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0010 | 37.0000 |
|
| LCLC-103H | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LCLC-103H | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| LCLC-103H | Telomerase Inhibitor IX | GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LCLC-103H | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LCLC-103H | Teniposide | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | TGX-115 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LCLC-103H | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| LCLC-103H | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LCLC-103H | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LCLC-103H | Tivozanib | GDSC1,CTRP2 | 0.0005 | 17.0000 |
|
| LCLC-103H | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LCLC-103H | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| LCLC-103H | Tozasertib | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | Tretinoin | GDSC1,CTRP2,CTRP1 | 0.0041 | 66.0000 |
|
| LCLC-103H | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| LCLC-103H | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| LCLC-103H | triacsin C | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LCLC-103H | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | triptolide | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| LCLC-103H | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | Tubastatin A | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | TW 37 | GDSC1,GDSC2,CTRP2 | 0.0010 | 5.0000 |
|
| LCLC-103H | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | ubistatin B | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| LCLC-103H | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | UNC0638 | GDSC1,GDSC2,CTRP2 | 0.0010 | 40.0000 |
|
| LCLC-103H | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LCLC-103H | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LCLC-103H | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| LCLC-103H | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LCLC-103H | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LCLC-103H | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LCLC-103H | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LCLC-103H | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| LCLC-103H | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LCLC-103H | Vismodegib | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| LCLC-103H | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | Vorinostat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LCLC-103H | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0320 | 66.0000 |
|
| LCLC-103H | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| LCLC-103H | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| LCLC-103H | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LCLC-103H | WAY-362450 | CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LCLC-103H | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | WT-161 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| LCLC-103H | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LCLC-103H | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | XAV939 | GDSC1,GDSC2,CTRP1 | 0.0100 | 37.0000 |
|
| LCLC-103H | XL765 | CTRP2 | 0.0020 | 33.0000 |
|
| LCLC-103H | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| LCLC-103H | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LCLC-103H | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| LCLC-103H | YM-022 | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| LCLC-103H | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| LCLC-103H | zebularine | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| LCLC-103H | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| LCLC-103H | zileuton | CTRP1 | 0.2603 | 33.3330 |
|
| LCLC-103H | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LCLC-103H | ZM447439 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LCLC-103H | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| LCLC-103H | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC